Chloroquine has well-documented safety data and adverse effect profiles
the verdict
SUPPORTED
the evidence backs this
confidence 80/100
Chloroquine possesses well-documented safety data and adverse effect profiles, supported by extensive clinical use and pharmacovigilance studies detailing risks such as ocular and cardiac events.
Evidence for · 4
Chloroquine and hydroxychloroquine: Immunomodulatory effects in autoimmune diseases.
2025 · cited by 5
Discusses the established clinical applications and long-term side effects of chloroquine and hydroxychloroquine in managing autoimmune diseases.
See more details
More for · 3
Safety profile of chloroquine and hydroxychloroquine: an analysis of the FDA Adverse Event Reporting System (FAERS) database
2020 · cited by 2
Analyzes the safety profile and adverse events of chloroquine using real-world FDA pharmacovigilance data.
Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS).
2025 · cited by 1
Provides real-world evidence from the FAERS database regarding the ocular safety profile and specific risks associated with chloroquine and hydroxychloroquine.
The Role of Hydroxychloroquine in the Management of Rheumatic Disorders: A Comprehensive Review.
2025 · cited by 1
Notes that while widely regarded as safe for rheumatic disorders, chloroquine and hydroxychloroquine have well-documented potential side effects requiring careful evaluation.